Overview
Biogened is a company with pharmaceutical roots that produces and distributes Dermedic dermocosmetics for sensitive-skin care. The products use patented combinations of active ingredients and are available in more than 40 countries.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 19.00
- High
- PLN 19.90
- Low
- PLN 18.90
- Volume
- 7
- Avg. vol.
- 79.4
- Market cap
- PLN 48.88M
- P/E ratio
- 9.52
- EPS
- PLN 2.09
- Shares outstanding
- 2.46M
- 52-week
- PLN 18.40 – 22.40
- Dividend yield
- 2.51%
- Dividend
- PLN 0.50
- Ex dividend date
- Sep 10, 2026
- ISIN
- PLBIOGN00018
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 8.32m | USD 712.86k | USD 369.80k |
| Q1 2026 | USD 7.65m | USD 1.28m | USD 690.71k |
| Q4 2025 | USD 7.08m | USD 380.96k | USD 218.99k |
| Q3 2025 | USD 5.96m | USD 142.14k | USD 2.01k |
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2000-09-01. Active
12 1090 2705 0000 0001 5575 3990
51 1600 1462 1082 4559 6000 0024
47 1020 3352 0000 1902 0174 3731
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $231.2K$231,228 |
Buildings and premises | $3.9M$3,863,607 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 16, 2015 | Commercial Companies Code notice |
Public aid
10 public aid cases recorded, with a total value of $1,268,560.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 12, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,661$2,661 | Energa - Obrót S.A. | |
| Apr 23, 2025 | Regional investment aid | $224.4K$224,424 | Marszałek Województwa Łódzkiego | |
| Apr 23, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $20,696$20,696 | Marszałek Województwa Łódzkiego |
European Funds
7 projects co-financed from European Funds recorded, with total EU co-financing of $1,243,403.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-08-12 | Wdrożenie własnych wyników badań w celu wprowadzenia nowego produktu z wykorzystaniem kompleksu MELUMIN w kosmetyce | $250.6K$250,564 | Fundusze Europejskie dla Łódzkiego 2021-2027 | |
| 2024-07-01 | Zakup infrastruktury produkcyjnej w celu wdrożenia na rynek własnych badań z wykorzystaniem kompleksu MELUMIN w kosmetyce | $250.6K$250,564 | Fundusze Europejskie dla Łódzkiego 2021-2027 | |
| 2024-05-13 | Wejście na nowe rynki zbytu przez firmę Biogened | $89,473$89,473 | Fundusze Europejskie dla Łódzkiego 2021-2027 |
Tenders
No recorded participation in tenders.
Trademarks
Biogened currently holds no active trademarks with the Polish Patent Office. 23 marks have expired or were not registered. The first mark was filed in 2002.
| Mark | Protected until | |
|---|---|---|
| FertiPRO | – | |
| DERMEDIC Emolient(word) | – | |
| DERMEDIC AquaGold SPECJALISTYCZNE NAWILŻENIE SKÓRY | – | |
| ELLEXIR - ZASTRZYK MŁODOŚCI W KREMIE(word) | – | |
| HERBA BOTANIC | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Two members of the management board, or a member of the management board jointly with a commercial proxy, are authorised to submit declarations of will.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company Biogened.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DR. Miele Cosmed GroupS.A. | $127,557,006.53 | dr-miele.eu | ||
| Oceanicsp. z o.o. | $82,901,772.15 | oceanic.com.pl | ||
| Delia Cosmeticssp. z o.o. | $52,625,062.10 | delia.pl | ||
| DAX Cosmeticssp. z o.o. | $45,596,740.62 | dax.com.pl | ||
| Forte Swedensp. z o.o. | $15,796,826.05 | forte-sweden.com | ||
| Flosleksp. z o.o. | $10,990,930.54 | floslek.pl | ||
| TargetS.A. | $10,537,895.36 | target.com.pl | ||
| Equalan Pharma Europesp. z o.o. | $6,273,288.20 | equalanpharma.eu | ||
| Dermena Labsp. z o.o. | $4,754,650.63 | dermena-lab.com | ||
| Cerko sp. z o.o.sp. k. | $3,120,699.32 | cerko.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-04-12 | Share capital change (22,563,190.00 PLN → 24,563,190.00 PLN) | |
| 2016-02-22 | Share capital change (18,563,190.00 PLN → 22,563,190.00 PLN) | |
| 2016-02-22 | PKD change (Removed: 21.20.Z) | |
| 2015-03-03 | Share capital change (14,563,190.00 PLN → 18,563,190.00 PLN) | |
| 2015-03-03 | PKD change (Removed: 10.86.Z, 10.89.Z, 20.20.Z, 20.41.Z, 32.50.Z, 46.90.Z, 47.2, 47.73.Z, 47.74.Z, 58.1, 58.2, 62.01.Z, 63.1, 64.20.Z, 68.3, 70.10.Z, 70.2, 73.1, 73.20.Z, 78.10.Z, 78.20.Z, 78.30.Z, 82.30.Z, 85.59, 86.10.Z, 86.2, 96.09.Z) |
FAQ
Last updated: 2026-07-04